Crossmark Global Holdings Inc. Reduces Stock Position in Maximus, Inc. (NYSE:MMS)

Crossmark Global Holdings Inc. lowered its position in shares of Maximus, Inc. (NYSE:MMS) by 6.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,882 shares of the health services provider’s stock after selling 270 shares during the period. Crossmark Global Holdings Inc.’s holdings in Maximus were worth $290,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of MMS. Assenagon Asset Management S.A. increased its position in shares of Maximus by 277.0% in the 3rd quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider’s stock valued at $81,878,000 after acquiring an additional 645,760 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Maximus by 942.9% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock valued at $27,707,000 after acquiring an additional 292,300 shares in the last quarter. Millennium Management LLC grew its stake in Maximus by 150.4% during the 2nd quarter. Millennium Management LLC now owns 406,075 shares of the health services provider’s stock valued at $34,801,000 after acquiring an additional 243,890 shares in the last quarter. Reinhart Partners LLC. lifted its position in Maximus by 43.5% during the fourth quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider’s stock worth $41,143,000 after buying an additional 167,019 shares in the last quarter. Finally, Sio Capital Management LLC acquired a new position in shares of Maximus during the 3rd quarter valued at about $14,453,000. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Stock Performance

NYSE MMS opened at $76.32 on Monday. Maximus, Inc. has a fifty-two week low of $69.72 and a fifty-two week high of $93.97. The business has a fifty day moving average of $74.82 and a 200-day moving average of $84.35. The stock has a market cap of $4.60 billion, a price-to-earnings ratio of 15.26 and a beta of 0.73. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.57%. The ex-dividend date of this dividend is Friday, February 14th. Maximus’s payout ratio is currently 24.00%.

Insider Buying and Selling at Maximus

In other Maximus news, CEO Bruce Caswell purchased 3,500 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The stock was bought at an average price of $70.64 per share, with a total value of $247,240.00. Following the completion of the purchase, the chief executive officer now owns 275,929 shares in the company, valued at $19,491,624.56. This trade represents a 1.28 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michelle F. Link sold 2,208 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the sale, the insider now owns 6,567 shares of the company’s stock, valued at $484,841.61. This trade represents a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have purchased 7,063 shares of company stock valued at $502,017 over the last three months. 1.40% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on MMS shares. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a research report on Thursday, January 2nd. StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a report on Friday, December 27th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.